RACK1 degrades MAVS to promote bovine ephemeral fever virus replication via upregulating E3 ubiquitin ligase STUB1.


Journal

Veterinary microbiology
ISSN: 1873-2542
Titre abrégé: Vet Microbiol
Pays: Netherlands
ID NLM: 7705469

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 21 12 2020
accepted: 25 04 2021
pubmed: 4 5 2021
medline: 25 9 2021
entrez: 3 5 2021
Statut: ppublish

Résumé

Receptors for activated C kinase 1 (RACK1) could competitively combine with mitochondrial antiviral signaling protein (MAVS) to inhibit the type I interferon (IFN) signaling pathway during viral infection in vitro. However, whether RACK1 can degrade MAVS to enhance viral replication is still unknown. In this study, we found that bovine epidemic fever virus (BEFV) infection triggered the expression of RACK1. Overexpression of RACK1 promoted BEFV replication, while knockdown of RACK1 inhibited the replication of BEFV. Further research showed that RACK1 inhibited the type I IFN signaling pathway during BEFV infection by degrading MAVS, and RACK1 degraded MAVS via the ubiquitin-proteasome system. Mechanistically, RACK1 up-regulated the expression of E3 ubiquitin ligase STIP1 homology and U-box containing protein 1 (STUB1), thereby promoting the ubiquitination and degradation of MAVS. In addition, RACK1 degraded MAVS by enhancing the interaction between STUB1 and MAVS but not via its interaction with STUB1. Overall, our study reveals a novel mechanism by which RACK1 inhibits the type I IFN signaling pathway to BEFV infection through degradation of MAVS, thereby promoting viral infection. These findings provide a new perspective for the MAVS degradation regulated by RACK1.

Identifiants

pubmed: 33940459
pii: S0378-1135(21)00119-X
doi: 10.1016/j.vetmic.2021.109096
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Interferon Type I 0
Receptors for Activated C Kinase 0
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109096

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Yangyang Zhang (Y)

Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, 250014, China. Electronic address: abyangyangzhang@163.com.

Peili Hou (P)

Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, 250014, China. Electronic address: apeilihou@163.com.

Daniel Chang He (DC)

International Department, High School Attached to Shandong Normal University, Jinan, 250014, China. Electronic address: danielchanghe@163.com.

Hongmei Wang (H)

Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, 250014, China. Electronic address: hongmeiwang@sdnu.edu.cn.

Hongbin He (H)

Ruminant Diseases Research Center, College of Life Sciences, Shandong Normal University, Jinan, 250014, China. Electronic address: hongbinhe@sdnu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH